In Silico Dose Prediction for Long-Acting Rilpivirine and Cabotegravir Administration to Children and Adolescents. (2018)

First Author: Rajoli RKR
Attributed to:  Towards NanoMedicine Interventions for HIV/AIDS funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s40262-017-0557-x

PubMed Identifier: 28540638

Publication URI: http://europepmc.org/abstract/MED/28540638

Type: Journal Article/Review

Volume: 57

Parent Publication: Clinical pharmacokinetics

Issue: 2

ISSN: 0312-5963